ECONOMIC OUTCOMES OF BIORESORBABLE VASCULAR SCAFFOLDS VERSUS EVEROLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION: ONE YEAR RESULTS FROM THE ABSORB III TRIAL
2016 ◽
Vol 67
(13)
◽
pp. 19
2003 ◽
Vol 41
(6)
◽
pp. 23
◽
2001 ◽
Vol 54
(4)
◽
pp. 448-453
◽
2017 ◽
Vol 10
(8)
◽
pp. 774-782
◽
2003 ◽
Vol 91
(10)
◽
pp. 1168-1172
◽
Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization
2003 ◽
Vol 92
(5)
◽
pp. 582-583
◽
1998 ◽
Vol 31
(2)
◽
pp. 179A-180A